MedTrace Logo

A Clinical Study of EUS-RFA for Inoperable Pancreatic Ductal Adenocarcinoma

NCT03444948 · Status: SUSPENDED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 108

Last updated 2026-04-23

No results posted yet for this study

Summary

To assess if endoscopic ultrasound-guided radiofrequency ablation application in patients with inoperable pancreatic cancer confers survival benefit when compared to patients receiving standard medical care.

Conditions

Interventions

DEVICE

EUS-RFA using Habib Tm as a probe

3 EUS-RFA interventions at 1-month interval

PROCEDURE

EUS

Standard intervention

Sponsors & Collaborators

  • Centre hospitalier de l'Université de Montréal (CHUM)

    lead OTHER

Principal Investigators

  • ANAND V SAHAI, MD · Centre de Recherche du Centre Hospitalier de l'Université de Montréal

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-02-14
Primary Completion
2028-06-30
Completion
2028-12-01

Countries

  • Canada

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03444948 on ClinicalTrials.gov